22 March 2018
News and Views
Links and Services
November's publication of the Annals of Internal Medicine examines the use of elbasvir–grazoprevir to treat Hepatitis C virus infection in persons receiving opioid agonist therapy.
Hepatitis C virus (HCV) infection is common in persons who inject drugs.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors